Articles by Peter H. Jones (11)

Efficacy and Safety of Multi-drug Therapy for Hypertriglceridemia

Venkat Polsani, Christie M. Ballantyne, Peter H. Jones, Vijay Nambi, Salim S. Virani and Daniele Zoch

Journal of Clinical Lipidology 2 ( 3 ): 204 - 205 , 2008

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination with Rosuvastatin in Patients with Mixed Dyslipidemia: A Phase 3 Study

Peter H. Jones, Susan M. Buttler, Michael H. Davidson, Moti L. Kashyap, Maureen T. Kelly, Carolyn M. Setze, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 3 ): 218 - 219 , 2008

Effects of ABT-335 in Combination with Rosuvastatin on Low-Density Lipoprotein Particle Size in Patients with Mixed Dyslipidemia

Peter H. Jones, Dawn M. Carlson, Thomas Dayspring, Maureen T. Kelly, Aditya Lele, Carolyn M. Setze and Darryl J. Sleep

Journal of Clinical Lipidology 2 ( 3 ): 219 - 220 , 2008

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia

Harold E. Bays, Peter H. Jones, Syed M. Mohiuddin, Maureen T. Kelly, Hsiaoming Sun, Carolyn M. Setze, Susan M. Buttler, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 2 ( 6 ): 426 - 435 , 2008

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies

Peter H. Jones, Michael H. Davidson, Anne C. Goldberg, Carl J. Pepine, Maureen T. Kelly, Susan M. Buttler, Carolyn M. Setze, Aditya Lele, Darryl J. Sleep and James C. Stolzenbach

Journal of Clinical Lipidology 3 ( 2 ): 125 - 137 , 2009

Efficacy and tolerability of multidrug therapy for hypertriglyceridemia

Venkateshwar R. Polsani, Vijay Nambi, Salim S. Virani, Daniele Zoch, Eric Y. Yang, Peter H. Jones and Christie M. Ballantyne

Journal of Clinical Lipidology 3 ( 5 ): 341 - 344 , 2009

Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training

Smita I. Negi, Lynne Steinberg, Venkateshwar R. Polsani, Saqib A. Gowani, Vijay Nambi, Varinder Kumar, Victor Marinescu, Peter H. Jones, Laura A. Petersen, Christie M. Ballantyne and Salim S. Virani

Journal of Clinical Lipidology 6 ( 1 ): 50 - 57 , 2012

Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analysis of controlled studies

Eli M. Roth, Robert S. Rosenson, Peter H. Jones, Michael H. Davidson, Maureen T. Kelly, Carolyn M. Setze, Aditya Lele and Kamlesh Thakker

Journal of Clinical Lipidology 6 ( 6 ): 534 - 544 , 2012

A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease

Smita I. Negi, Ariel Brautbar, Salim S. Virani, Aashish Anand, Eliana Polisecki, Bela F. Asztalos, Christie M. Ballantyne, Ernst J. Schaefer and Peter H. Jones

Journal of Clinical Lipidology 7 ( 1 ): 82 - 87 , 2013

Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome

Madhuri Vasudevan, Urbain Tchoua, Baiba K. Gillard, Peter H. Jones, Christie M. Ballantyne and Henry J. Pownall

Journal of Clinical Lipidology 7 ( 6 ): 661 - 670 , 2013

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - executive summary

Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold E. Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson and W. Virgil Brown

Journal of Clinical Lipidology 8 ( 5 ): 473 - 488 , 2014